SHANNON HALLMAN: Open Payments
NPI 1528133915 · WEST COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,542 in 116 payments from 45 companies in 2025. Trend: 2023 $1,478 · 2024 $1,918 · 2025 $2,542
Food & beverage: $2,542
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 10 | $235 |
| Incyte Corporation | 7 | $211 |
| E.R. Squibb & Sons, L.L.C. | 10 | $150 |
| Janssen Biotech, Inc. | 6 | $133 |
| ABBVIE INC. | 6 | $127 |
| AstraZeneca Pharmaceuticals LP | 6 | $124 |
| Daiichi Sankyo Inc. | 5 | $118 |
| Merck Sharp & Dohme LLC | 4 | $105 |
| Genentech USA, Inc. | 5 | $100 |
| PFIZER INC. | 5 | $90 |
Products named: Enhertu, KEYTRUDA, OPDIVO, ERLEADA, SCEMBLIX, REBLOZYL, JAKAFI, Lenvima.
Industry payments across SC — which companies pay providers there.
